The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Advancing country-led sustainable digital health transformation across PEPFAR-supported countries through informatics workforce capacity development to end HIV/AIDS and TB as a public health threat by 2030 under PEPFAR |
93.067 |
CDC-RFA-JG-25-0055 |
Improving HIV prevention and treatment in the Dominican Republic with a focus on priority populations under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0069 |
Improving quality of care and health outcomes through innovative systems and technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0050 |
Rural Health Care Services Outreach Program |
93.912 |
HRSA-25-038 |
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) |
93.866 |
PAR-25-297 |
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) |
93.173, 93.242, 93.286, 93.313, 93.399, 93.853, 93.865, 93.867, 93.989 |
PAR-25-242 |
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) |
93.242 |
PAR-25-310 |
Supporting sustainable, accessible, integrated and quality laboratory systems for HIV/TB and related health threats in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0164 |
Strengthening economic analysis and capacity in support of program management for HIV, TB, and related health threats in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0056 |
Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0057 |
Strengthening the Government of Namibia's health information systems (HIS) to improve public health programs under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0093 |
Sustaining HIV and TB epidemic control in Lesotho through health system strengthening and technical assistance under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0078 |
AEIF 2025 |
19.040 |
PDS-GUA-FY25-01 |
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) |
93.855 |
PAR-25-251 |
FY 2025 Competitive Funding Opportunity: Technology Transfer (T2) Program |
20.530 |
FTA-2025-002-TRI |
Strengthening the Botswana Ministry of Health (MOH) laboratory and health systems through technical assistance (TA) to effectively manage and sustain a quality HIV/TB program in Botswana under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0084 |
Provide technical assistance (TA) to support the Botswana Ministry of Health (MOH) implement policies and programs across the HIV clinical and prevention cascade under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0082 |
Provide technical assistance to the Botswana Ministry of Health to implement HIV/TB policies and services for children and adolescents living with HIV including mental health and psychosocial support and pregnant and breastfeeding women under PEPFAR |
93.067 |
CDC-RFA-JG-25-0083 |
Strengthening comprehensive HIV and TB services and health systems in high-burden areas of Namibia under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0092 |
Implementation of integrated, resilient, and sustainable health systems for HIV/TB epidemic control in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0088 |
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) |
93.213 |
PAR-25-269 |
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) |
93.855 |
PAR-25-300 |
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required) |
93.279, 93.307, 93.310, 93.313 |
RFA-DA-26-003 |
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required) |
93.279, 93.310, 93.313 |
RFA-DA-26-004 |
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
93.213 |
PAR-25-270 |
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) |
93.213 |
PAR-25-271 |
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) |
93.865 |
PAR-25-266 |
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) |
93.865 |
PAR-25-265 |
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) |
93.853 |
PAR-25-215 |
NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed) |
93.398 |
PAR-24-320 |
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) |
93.853 |
PAR-25-216 |
In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed |
93.310 |
RFA-RM-24-012 |
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed) |
93.113, 93.143 |
RFA-ES-25-003 |
NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed) |
93.398 |
PAR-24-317 |
NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required) |
93.398 |
PAR-24-318 |
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
93.121 |
PAR-25-188 |
Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-24-049 |
Strengthening and modernizing sustainable public health systems and workforce in Uganda for data science, informatics, surveys, and surveillance for timely, accurate, and integrated data for action under PEPFAR |
93.067 |
CDC-RFA-JG-25-0047 |
Supporting the implementation of comprehensive HIV prevention and treatment programs to achieve and sustain epidemic control in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0099 |
Support for laboratory diagnosis and monitoring to scale up and improve HIV/AIDS care and treatment services for Caribbean countries supported under the President's Emergency Plan for AIDS Relief (PEPFAR) |
93.067 |
CDC-RFA-JG-25-0065 |
Search Results 281-320 of 22029 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 [Next] |